Biocept, Inc. Granted U.S. Patent For Blood Collection And Transport Tube

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the diagnosis and treatment of cancer, today announced receipt of a U.S. patent for its blood collection and transport preservative. The patent, entitled USE OF DIAZOLIDINYL UREA FOR ANTI-CLUMPING OF BIOLOGICAL SAMPLES, was issued as U.S. Patent No. 9,040,255.

Help employers find you! Check out all the jobs and post your resume.